Both require a prescription and ongoing medical supervision to be used safely and effectively
As a GLP-1RA,102 albiglutide works by stimulating insulin release and reducing glucagon production, leading to improved blood sugar control in patients with T2DM.102,103 Albiglutide is a long-acting GLP-1RA injected subcutaneously once a week
Animal studies suggest that GLP-1 signaling can influence mitochondrial dynamics and oxidative phosphorylation
It's important to acknowledge that these are common, with studies indicating that a significant percentage of users (reports range from 40% up to 85%) experience issues like nausea, vomiting, diarrhea, constipation, bloating, or heartburn, particularly when first starting the medication or increasing the dose
US pricing at $1,000+ per month generates a gross margin of 80 to 90 percent